MicroQuin
PrivateLast Round
Grant
Feb 1, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
MicroQuin operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Grant round in February 2025.
MicroQuin is a biotechnology company developing therapeutics that modulate the intracellular environment to treat cancer, neurodegenerative disorders, and viral infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MicroQuin Comparables
Compare MicroQuin with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EtiraRx | 82% | |
| Celloram Inc. | 78% | |
| Aprea Therapeutics | 72% |
For institutional investors. Book with your work email.
MicroQuin Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 1, 2025 | ||||
| Grant | Oct 18, 2018 | ||||
| Accelerator | May 23, 2018 |
For institutional investors. Book with your work email.
MicroQuin Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| United States Department of Defense | Grant |
| MassChallenge Israel | Grant, Accelerator |
| Congressionally Directed Medical Research Programs | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 36% MoM.
- Feb 1, 2025
Received funding from Congressionally Directed Medical Research Programs.
For institutional investors. Book with your work email.
MicroQuin Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MicroQuin's valuation, stock price, and market status.
Is MicroQuin a public or private company?
MicroQuin is a private company.
What is the current stock price of MicroQuin?
MicroQuin is a private company, so its shares have no public market price. Caplight tracks MicroQuin's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MicroQuin worth (valuation)?
Valuation information for MicroQuin is not publicly available.
Can I buy MicroQuin stock?
MicroQuin shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MicroQuin's last funding round?
MicroQuin's most recent funding round was Grant on February 1, 2025.
Who are the main investors in MicroQuin?
Key investors in MicroQuin include United States Department of Defense, MassChallenge Israel, Congressionally Directed Medical Research Programs.
Will MicroQuin IPO soon?
No public IPO plans have been announced for MicroQuin.
How can I track MicroQuin secondary market activity?
Caplight tracks bids, offers, and trades in MicroQuin's shares on secondary markets.